Eight characteristics, including age, platelets, BM blast percentage, and mutations in ASXL1, EZH2, RUNX1, ETV6 and TP53, were associated with MDS patient OS (Figure 4A, Supplementary Table 2). This evidence concerns the gene ETV6 and myelodysplastic syndrome.